友芝友生物-B（02496）于2026年3月4日提交的月报显示，截至2026年2月28日，公司注册股本合计人民币193,849,200元，较上月无任何变动。H股数量维持111,468,814股，内资股数量为75,510,642股，非上市外资股数量为6,869,744股，三类股份的已发行数量均无新增或回购活动。
公司已于2024年6月27日采纳2024年H股购股权计划，目前未见因行使期权而导致的股份发行或库存股转让数量变动。公告同时提及，获联交所批准转换为H股的68,010,299股非上市股份仍在办理转换过程中。
公司确认符合香港联交所上市规则对公众持股量的要求。公告由联席公司秘书郑建华签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.